Ionis to purchase 24% stake in Akcea Therapeutics for $500m

This article was originally published here

Based in Boston of Massachusetts, Akcea Therapeutics is engaged in the development and commercialisation of medicines for the treatment of patients with serious and rare diseases. Under the

The post Ionis to purchase 24% stake in Akcea Therapeutics for $500m appeared first on Pharmaceutical Business review.